Discover
Tick Boot Camp
Tick Boot Camp
Author: Matt Sabatello and Rich Johannesen
Subscribed: 61Played: 2,943Subscribe
Share
© Copyright 2026
Description
Tick Boot Camp is a Lyme disease and tick-borne illness podcast featuring interviews with leading doctors, researchers, scientists, patients, advocates, and experts. Explore Lyme disease symptoms, testing, diagnosis, treatment, recovery, chronic Lyme disease, coinfections, PANS/PANDAS, MCAS, neurological symptoms, emerging research, and the latest advances in tick-borne disease care. Through expert education and powerful patient stories, Tick Boot Camp provides hope, validation, practical information, and a community for people navigating Lyme disease and complex chronic illness.
631 Episodes
Reverse
Read transcriptWhat happens when two Lyme disease patients take the hardest parts of their own healthcare journeys and build the resource they wish had existed when they were sick?
In this episode of the Tick Boot Camp Podcast, co-hosts Matt Sabatello and Richard Johannesen sit down with Kevin Williams and Jaime Intile, co-founders of Ravel Health, a virtual healthcare platform connecting people living with Lyme disease, mold illness, tick-borne infections, Long COVID, and other complex chronic illnesses with vetted licensed providers.
Kevin and Jaime share deeply personal Lyme disease journeys that ultimately brought them together to create Ravel Health. Their stories include years of unexplained symptoms, difficulty finding knowledgeable practitioners, Lyme and co-infection diagnoses, mold exposure, nervous system dysregulation, herbal and pharmaceutical treatment approaches, financial barriers, long provider waitlists, and the challenge of knowing where to turn next.
They also explain how Ravel Health is attempting to remove some of those barriers through personalized provider matching, virtual appointments, conventional, functional, and integrative treatment options, transparent pricing, provider vetting, and a new nationwide recent tick-bite care program.
Kevin Williams' 10-Year Journey to a Lyme Disease Diagnosis
Kevin's health challenges began years before he knew Lyme disease was involved.
After experiencing multiple significant concussions while playing soccer, Kevin developed post-concussive symptoms that lasted approximately two and a half years. Several years later, new and unexplained health problems began appearing.
His early symptoms included:
Cramping in his hands and feet
Migratory muscle pain
Gastrointestinal problems
Brain fog
Dizziness
Memory problems
Neurological symptoms
Inner-ear and balance problems
Difficulty walking
Kevin spent years visiting primary care physicians, neurologists, ENTs, and other specialists without receiving an explanation that connected his symptoms.
At one point, a physician essentially told him that because his condition did not appear life-threatening, he might simply have to learn to live with it.
Lyme disease was not seriously considered until Kevin eventually became a patient of Dr. Jill Carnahan, after spending roughly two and a half years on her waiting list.
Kevin says his diagnosis was based largely on his clinical presentation along with testing that indicated Lyme disease and Babesia. His journey later expanded to include investigation of Bartonella and mold-related illness.
Learn more about Dr. Jill Carnahan and her Tick Boot Camp appearances:
Dr. Jill Carnahan on Tick Boot Camp
Antibiotics, Disulfiram, Mold, and a Difficult Treatment Journey
After receiving his diagnosis, Kevin initially pursued a more conventional Lyme treatment path.
His experience included medications such as doxycycline and azithromycin, followed later by disulfiram.
Kevin describes having mixed results with disulfiram. He noticed improvement in some neuropsychiatric symptoms, including the intense irritability and emotional reactivity he had been experiencing, but ultimately developed significant problems while taking the medication.
After stopping disulfiram, he experienced severe neuropathy and facial symptoms that took months to improve.
Kevin's journey later turned toward mold.
Working with a provider familiar with the Shoemaker approach, Kevin investigated whether mold exposure might be contributing to his continuing illness. Although he struggled with parts of the protocol and was unable to tolerate cholestyramine well, he ultimately found that addressing his mold environment and incorporating neurofeedback were two of the interventions that made the biggest difference for him personally.
His experience reinforces one of the recurring themes of this episode: complex chronic illness rarely fits neatly into a single diagnosis, treatment, or protocol.
Nervous System Regulation vs. Persistent Biological Triggers
Kevin also discusses nervous system dysregulation and his experience with neurofeedback.
After years of concussions, Lyme disease, co-infections, chronic symptoms, and treatment stress, Kevin describes feeling as though his nervous system had been operating in a prolonged state of fight-or-flight.
Neurofeedback helped reduce some of that physiological intensity.
But Kevin does not frame nervous system work as proof that ongoing symptoms are simply generated by the brain. Instead, the conversation explores a much more nuanced question: How do persistent biological triggers, infections, environmental exposures, inflammation, trauma, and nervous system dysregulation interact in complex chronic illness?
Matt connects this discussion to a recent Tick Boot Camp conversation with Mount Sinai clinical neuropsychologist Dr. Jacqueline Becker, who discussed cognitive rehabilitation, persistent symptoms, and the importance of not automatically assuming that all continuing neurological symptoms can be explained by maladaptive brain pathways alone.
Listen to that conversation:
Dr. Jacqueline Becker on Post-Treatment Lyme Disease and Cognitive Rehabilitation
Jaime Intile's Lyme Disease Story
Jaime's Lyme journey began very differently.
Growing up in New Jersey, she remembers finding an engorged tick attached to her scalp while she was in third grade. Shortly afterward, she developed a rash that was diagnosed at the time as ringworm.
Jaime cannot know with certainty whether that childhood bite caused the illness she experienced decades later, but looking back, it became one piece of a much larger health story.
In her mid-30s, during an intensely stressful period of her life, Jaime began feeling increasingly unwell.
Her symptoms included:
Persistent unexplained rashes
Air hunger and breathing difficulties
Brain fog
Muscle aches
Fatigue
Neurological and cognitive symptoms
Increasing difficulty functioning normally
She repeatedly sought medical help but was told that testing looked normal or that her symptoms were not medically concerning.
One physician suggested she see a psychiatrist, drink wine, eat a burger, and go for a run.
For patients who have spent years being told that nothing is wrong despite knowing their bodies are changing, Jaime's story will sound painfully familiar.
The Dog Attack That Changed Jaime's Health
Years later, while living in Colorado, Jaime was severely bitten by a neighbor's dog.
She does not believe the dog gave her Lyme disease. Rather, Jaime describes the physical and emotional trauma of the attack as an event after which her existing health problems dramatically worsened.
She experienced profound depression, difficulty communicating and functioning, worsening physical symptoms, and eventually became unable to continue operating her executive coaching business.
That period forced her to devote herself more fully to finding answers.
Eventually, Jaime began working with the Sound Clinic in Colorado and underwent testing that she says identified:
Lyme disease
Babesia
Bartonella
Ehrlichia
Receiving a diagnosis finally gave her a direction, but it also raised a new question:
Now what?
Jaime's Herbal and Holistic Approach
Unlike Kevin, Jaime knew that she personally did not want antibiotics to be the centerpiece of her treatment.
She pursued a primarily herbal and lifestyle-focused approach.
Her recovery journey included changes involving:
Herbal protocols
Supplements
Nutrition
Gluten and dairy reduction
Reducing household chemical exposures
Infrared sauna
Meditation
Yoga
Hiking and movement
Stress management
Reiki and other complementary therapies
Greater awareness of how her body responded to different interventions
Jaime emphasizes that her choices are not an argument against antibiotics.
Instead, one of the lessons that eventually became central to Ravel Health is that different patients want and need different approaches.
Ravel therefore works with providers representing conventional, functional, and integrative treatment philosophies.
Two Lyme Patients Build the Platform They Needed
Kevin and Jaime were introduced by a mutual connection during the COVID-19 pandemic.
Jaime had been operating wellness retreats before COVID disrupted in-person events. Kevin had already begun exploring an earlier concept designed to help people struggling with Lyme disease.
They began talking in the summer of 2021.
The more they compared their experiences, the clearer something became:
They had both spent years trying to solve many of the same problems.
Finding knowledgeable doctors.
Knowing whom to trust.
Waiting months or years for appointments.
Finding clinicians licensed in the correct state.
Paying enormous out-of-pocket costs.
Trying to determine whether a doctor's treatment philosophy matched the patient's preferences.
Starting over when a provider relationship failed.
And attempting to navigate all of it while extremely sick.
Instead of building Ravel immediately, Kevin and Jaime spent roughly 12 to 18 months speaking with patients, physicians, organizations, and other people throughout the complex chronic illness community.
Ravel Health eventually launched a small pilot in October 2023 with approximately 30 patients and six providers.
The company's philosophy remains simple:
Build something they wish had existed when they were sick.
Learn more:
Ravel Health – Virtual Care for Complex Chronic Illness
What Is Ravel Health?
Kevin describes Ravel as a digital health platform providing virtual care services for people living with Lyme disease, mold illness, and complex chronic illness.
Jaime offers an even shorter description:
Affordable virtual care for patients with complex chronic illness.
Ravel currently connects patients with vetted licensed healthcare providers who understand conditions that frequently overlap or become difficult to manage within fragmented traditional healthcare systems.
These may include Lyme disease and tick-borne infections, mold-related
Feeling stuck in your Lyme disease recovery? What if you're making more progress than you realize—but the daily ups and downs make it difficult to see?
In this LIVE from ILADS episode of the Tick Boot Camp Podcast, co-host Rich Johannesen welcomes back Dr. Carolyn Mukai, ND, a naturopathic physician at Tandem Clinic in Vancouver, British Columbia, Canada, who specializes in Lyme disease, tick-borne infections, and complex chronic illness.
Recorded at the 2025 International Lyme and Associated Diseases Society (ILADS) Conference in San Antonio, Texas, this conversation explores one of the most frustrating experiences in chronic illness recovery: hitting a treatment plateau.
After appearing on Tick Boot Camp at a previous ILADS conference alongside her colleague Dr. Lynn Klassen, ND, Dr. Mukai returns as a conference presenter to discuss how practitioners can better support patients with complex, overlapping medical conditions.
She explains how tracking symptoms, measuring improvements, recognizing patterns, and reassessing treatment plans can help patients and practitioners understand whether meaningful progress is occurring.
The conversation also explores mast cell activation syndrome (MCAS), dysautonomia, hypermobility syndromes, mold-related concerns, financial barriers to treatment, and the importance of educating healthcare professionals.
Most importantly, Dr. Mukai reminds patients that recovery doesn't always follow a straight line—and sometimes recognizing progress requires looking at the bigger picture.
Meet Dr. Carolyn Mukai, ND
Dr. Carolyn Mukai is a naturopathic physician at Tandem Clinic in Vancouver, British Columbia.
She completed a two-year residency focused on vector-borne illness and complex chronic disease at Tandem Clinic.
Her clinical interests include Lyme disease, associated infections, complex chronic illness, mast cell activation syndrome, dysautonomia, hypermobility syndromes, and environmental health concerns.
Dr. Mukai also has personal experience navigating Lyme disease and chronic illness, which informs her patient-centered approach.
Alongside Dr. Lynn Klassen, she helps educate healthcare professionals through practitioner training programs designed to improve the assessment and management of complex chronic illness.
From ILADS Exhibitor to Conference Presenter
Rich begins the interview by welcoming Dr. Mukai back to Tick Boot Camp.
The two first met at a previous ILADS conference, where Dr. Mukai and Dr. Lynn Klassen were participating as exhibitors.
This year, they returned as presenters, sharing their clinical experiences and educational approaches with other healthcare professionals.
Dr. Mukai explains that education has always been central to their mission.
Whether working with patients or training practitioners, their goal is to make complicated medical conditions easier to understand and manage.
Their conference presentation explored strategies for addressing treatment plateaus in complicated vector-borne disease, including investigational adjunctive therapies.
During this interview, however, Rich focuses on a particularly important question for patients:
How can someone recognize when they've reached a plateau, and what can their healthcare team do about it?
What Is a Lyme Disease Treatment Plateau?
A treatment plateau occurs when a patient's symptoms or functioning stop showing meaningful improvement over a period of time.
For people managing Lyme disease or complex chronic illness, this can be discouraging.
A patient may initially experience improvements in fatigue, pain, cognitive function, or daily activities.
Then progress appears to slow or stop.
Rich explains that after interviewing hundreds of people affected by Lyme disease, he has noticed a recurring pattern.
Many patients describe periods of improvement followed by setbacks or stretches when they feel stuck.
Dr. Mukai agrees that this pattern is familiar in her clinical practice.
However, a plateau does not automatically mean an infection remains active or that treatment has failed.
Persistent symptoms can have multiple explanations, making careful reassessment important.
Why Recovery Doesn't Always Feel Like Progress
One of the most powerful moments in the interview comes when Dr. Mukai explains the difference between experiencing recovery day to day and looking at progress over several months.
When patients are living with symptoms every day, they naturally focus on how they feel in the moment.
A difficult morning, painful flare, or exhausting week can make previous improvements seem insignificant.
Dr. Mukai explains that when someone is focused on individual setbacks, they may struggle to recognize the larger pattern.
When you zoom in, you see the peaks and valleys. When you zoom out, you may discover an overall upward trajectory.
For example, a patient might still experience fatigue but notice that they can now complete activities that were impossible several months earlier.
Another person may continue experiencing brain fog but find that their pain has decreased or their sleep has improved.
These changes matter.
Dr. Mukai believes practitioners should help patients recognize improvements while continuing to validate the symptoms and limitations they experience.
Recovery experiences vary, and improvement cannot be guaranteed, but tracking meaningful changes can help patients make more informed decisions.
The Emotional Challenges of Treatment Plateaus
Rich asks Dr. Mukai about the emotional impact of feeling stuck.
For many patients, a plateau can bring uncertainty, frustration, and fear.
They may wonder whether their treatment is working, whether their symptoms will improve, or whether they have exhausted their options.
Dr. Mukai emphasizes that these feelings deserve acknowledgment.
Patients who are struggling may have difficulty recognizing progress, particularly when symptoms fluctuate.
She believes practitioners can help by explaining what they are observing, reviewing changes over time, and discussing realistic next steps.
The goal is not to dismiss setbacks or promise improvement.
Instead, it is to help patients feel supported and involved in decisions about their healthcare.
Tracking Lyme Disease Symptoms Every Four Weeks
One of the most practical takeaways from the interview is Dr. Mukai's structured approach to follow-up appointments.
She explains that her practice commonly reassesses patients approximately every four weeks.
During these visits, the team reviews symptoms and asks patients to estimate their overall level of improvement.
Dr. Mukai describes using percentage-based measurements.
For example, a patient might report feeling:
30% of their usual level of functioning
50% of their usual level of functioning
70% of their usual level of functioning
These percentages are subjective, but tracking them consistently can help reveal patterns.
A patient who reports 40% functioning during one appointment and 60% several months later may be experiencing meaningful changes even if symptoms remain.
The purpose is not to reduce someone's health to a number.
It is to create a reference point that can help patients and practitioners recognize changes over time.
Why Tracking Individual Symptoms Matters
Dr. Mukai explains that overall improvement percentages are useful, but evaluating individual symptoms can provide even more information.
For example, a patient might report the following changes between appointments:
Fatigue: Previously severe, now moderate.
Joint pain: Previously moderate, now mild.
Brain fog: Still severe, with little noticeable improvement.
Sleep quality: Previously poor, now gradually improving.
Daily functioning: Previously very limited, now able to complete more everyday activities.
This is an illustrative example, not actual patient data from the interview.
In this example, several symptoms have improved while cognitive difficulties remain unchanged.
That distinction may help the healthcare team determine which concerns require additional investigation.
Without consistent tracking, the patient might simply report feeling unwell and overlook meaningful changes in other areas.
Dr. Mukai believes that measuring symptoms over time helps both patients and practitioners make more informed decisions.
How Practitioners Identify a Treatment Plateau
Dr. Mukai explains that her team uses patient-reported improvements, symptom assessments, and questionnaires to evaluate progress.
If a patient's reported functioning remains relatively unchanged across multiple appointments, the practitioner may consider whether a plateau has occurred.
However, a single unchanged measurement does not necessarily indicate treatment failure.
The healthcare team may need to evaluate:
Whether symptoms have remained stable over time
Which symptoms are improving and which are not
Whether daily functioning has changed
Whether new symptoms or side effects have appeared
Whether other medical conditions require attention
Whether the existing treatment plan remains appropriate
Dr. Mukai emphasizes that a structured process helps practitioners make more thoughtful decisions.
Rather than automatically adding treatments, clinicians can review the available information and determine whether reassessment is needed.
Questionnaires Used in Complex Chronic Illness Care
Dr. Mukai discusses using questionnaires to organize symptoms and identify patterns.
Two tools mentioned during the interview are the MSIDS questionnaire and the Jill Crista mold questionnaire.
MSIDS Questionnaire
MSIDS stands for Multiple Systemic Infectious Disease Syndrome, a framework associated with Dr. Richard Horowitz.
The questionnaire organizes symptoms and potential contributors to complex illness.
It may support discussions between patients and practitioners but does not independently diagnose Lyme disease or active coinfections.
Jill Crista Mold Questionnaire
Dr. Mukai also discusses a questionnaire associated with Dr. Jill Crista that focuses on symp
What happens when Lyme disease patients reach a treatment plateau and continue struggling with fatigue, pain, and inflammation? Could ozone therapy offer additional support when conventional and integrative treatments have not produced the progress patients hoped for?
In this LIVE from ILADS episode of the Tick Boot Camp Podcast, co-host Rich Johannesen welcomes back Dr. Lynn Klassen, ND, a naturopathic physician specializing in Lyme disease and complex chronic illness and the founder of Tandem Clinic in Vancouver, British Columbia, Canada.
Recorded at the 2025 International Lyme and Associated Diseases Society (ILADS) Conference in San Antonio, Texas, this interview explores the potential role of ozone therapy, specifically single-pass major autohemotherapy (MAH), as an adjunctive treatment for patients with persistent symptoms.
After appearing on Tick Boot Camp during a previous ILADS conference alongside her colleague Dr. Carolyn Mukai, Dr. Klassen returns to discuss research presented at this year's conference.
Her presentation focused on a clinical case series involving patients with complex chronic illness who had reached treatment plateaus.
These patients continued experiencing symptoms such as fatigue, chronic pain, and skin-related complaints despite previous interventions.
Dr. Klassen explains why her team began exploring oxidative therapies and describes how single-pass ozone autohemotherapy is performed.
Rich guides the conversation from technical explanations toward practical questions patients want answered: What is ozone therapy? What happens during a treatment? Why might a clinician consider it? And what does the available evidence actually tell us?
This episode explores the science, theories, and clinical observations behind ozone therapy while highlighting the need for more rigorous research into its safety and effectiveness for Lyme disease.
Meet Dr. Lynn Klassen, ND
Dr. Lynn Klassen is a naturopathic physician and founder of Tandem Clinic in Vancouver, British Columbia.
Her practice focuses on Lyme disease, associated tick-borne infections, and complex chronic illness.
Dr. Klassen has been involved in practitioner education and the development of training opportunities for naturopathic physicians interested in vector-borne diseases.
She has also worked with Dr. Carolyn Mukai, ND, to expand access to specialized care and education for patients and healthcare professionals.
Her professional interests include:
Lyme disease and associated infections
Complex chronic illness
Integrative and naturopathic medicine
Adjunctive therapies
Practitioner education and mentorship
Collaborative patient care
Research into supportive treatment approaches
During the interview, Rich recalls meeting Dr. Klassen and Dr. Mukai at a previous ILADS conference when they were participating as exhibitors.
This year, Dr. Klassen returned as a conference speaker, presenting clinical observations involving ozone therapy.
From ILADS Exhibitor to Conference Speaker
Rich opens the interview by welcoming Dr. Klassen back to Tick Boot Camp.
The two joke about their first meeting, when Rich encouraged her and her colleague to participate in an interview.
This time, Dr. Klassen has returned to the conference in a different capacity.
Rather than exhibiting, she is presenting on the use of ozone therapy as adjunctive care for patients with complex chronic illness.
Her presentation focuses on patients whose symptoms had stopped improving despite previous treatment.
The discussion reflects a challenge familiar to many people living with persistent symptoms: reaching a point where progress becomes difficult to measure and patients and clinicians begin considering additional options.
Dr. Klassen explains that her team began exploring oxidative therapies in selected patients and presented their clinical observations as a case series.
A case series can describe patient experiences and generate research questions, but it cannot establish whether a treatment caused improvement or is effective compared with other approaches.
When Lyme Disease Patients Reach a Treatment Plateau
Dr. Klassen describes patients who continue experiencing symptoms despite undergoing treatment for complex chronic illness.
The symptoms discussed include:
Persistent fatigue
Chronic pain
Skin manifestations
Ongoing inflammatory complaints
Difficulty achieving further symptom improvement
She explains that these situations can prompt clinicians to reassess treatment plans and investigate additional approaches.
In her practice, one option being explored is ozone-based major autohemotherapy.
The intention is to use ozone therapy alongside other treatments rather than as a replacement for appropriate medical care.
However, persistent symptoms can have many causes, including other medical conditions, medication effects, sleep disorders, autonomic dysfunction, and complications unrelated to active infection.
A treatment plateau does not automatically indicate persistent Borrelia infection or the need for additional antimicrobial treatment.
What Is Ozone Therapy?
Ozone is a molecule composed of three oxygen atoms, represented chemically as O3.
It is a highly reactive oxidizing agent.
Ozone has recognized antimicrobial properties in certain environmental and industrial applications.
However, these properties do not establish that introducing ozone-treated blood into the body safely eliminates Lyme disease bacteria or other pathogens.
During the interview, Dr. Klassen discusses the theory that carefully controlled exposure to ozone may influence biological signaling pathways.
She describes possible effects involving:
Immune system regulation
Oxidative stress responses
Blood circulation
Oxygen delivery to tissues
Red blood cell function
Distribution of medications
These proposed mechanisms remain under investigation.
Clinical evidence has not established that ozone autohemotherapy reliably improves these functions or produces meaningful health benefits in patients with Lyme disease.
What Is Major Autohemotherapy?
One of the most educational parts of the conversation is Dr. Klassen's explanation of major autohemotherapy (MAH).
Rich asks her to explain the procedure in simple terms.
Dr. Klassen describes a process in which blood is withdrawn from a patient, exposed to a controlled ozone-oxygen gas mixture outside the body, and then reinfused.
The basic sequence she describes is:
Blood is withdrawn through an intravenous line into a specialized collection system.
The blood is mixed with an ozone-oxygen gas preparation.
The treated blood is returned to the patient through the intravenous system.
The procedure is sometimes called ozone autohemotherapy.
Importantly, this is different from directly injecting ozone gas into a vein, which can be dangerous.
Major autohemotherapy is still an invasive procedure involving blood handling and intravenous access. It requires appropriate equipment, infection-control practices, and qualified medical oversight.
What Does One-Pass Ozone Mean?
Dr. Klassen explains that her clinical presentation focuses on single-pass ozone autohemotherapy.
A pass refers to one cycle of withdrawing blood, exposing it to an ozone-oxygen mixture, and reinfusing it.
She contrasts this with more intensive approaches sometimes described as:
Ten-pass ozone therapy
Hyperbaric ozone therapy
Extracorporeal blood oxygenation and ozonation (EBOO)
These procedures differ in equipment, processing methods, and treatment protocols.
Dr. Klassen emphasizes that her team is investigating a comparatively limited single-pass approach rather than the more intensive techniques.
Rich appreciates the straightforward explanation because it helps patients understand what is involved.
Although single-pass therapy may sound less complicated than multi-pass systems, it still carries procedural and biological risks.
A lower number of passes does not independently establish safety or effectiveness.
Why Dr. Klassen Is Interested in Immune Modulation
Dr. Klassen explains that one of her main interests is the possibility that ozone therapy could influence immune system activity.
She describes the immune system as having multiple functions that need to remain appropriately balanced.
During infections and inflammatory conditions, immune signaling can become dysregulated.
Dr. Klassen discusses the theory that ozone exposure may influence certain immune responses and potentially reduce excessive inflammatory activity.
She also raises the possibility that it could support other aspects of immune function.
These are proposed biological effects rather than demonstrated clinical outcomes in Lyme disease patients.
Immune regulation is complex, and a therapy cannot be assumed to selectively calm harmful immune activity while strengthening beneficial responses.
More research is necessary to determine whether ozone autohemotherapy produces reproducible, clinically meaningful immune effects.
What Does an Overactive Immune System Feel Like?
Rich asks Dr. Klassen to explain immune hyperreactivity in terms that patients can understand.
She describes people who experience heightened sensitivity to everyday exposures.
Examples discussed include:
Reactions to certain foods
Sensitivity to soaps or fragrances
Increased discomfort around chemical exposures
Fatigue
Feeling overstimulated
Other symptoms associated with inflammatory or immune-related conditions
These experiences can be particularly difficult for people managing complex chronic illness.
However, food reactions, chemical sensitivities, fatigue, and overstimulation have many possible causes.
They do not necessarily indicate immune hyperreactivity, mast cell activation syndrome, or an underlying tick-borne infection.
Appropriate evaluation is important before attributing these symptoms to a particular mechanism.
Ozone Therapy and Tissue Oxygenation
Dr. Klassen also discusses the proposed relationship between ozone autohemotherapy and oxygen delive
What has changed in Lyme disease treatment over the past 15 years? Could herbal supplements, emerging medications, and new diagnostic technologies help physicians better understand persistent symptoms and complex tick-borne infections?
In this LIVE from ILADS episode of the Tick Boot Camp Podcast, co-host Rich Johannesen sits down with Dr. Samuel "Sam" Shor, MD, FILADS, a pioneering Lyme disease physician, researcher, former president of the International Lyme and Associated Diseases Society (ILADS), and recipient of the 2025 Pioneer in Lyme Award.
Recorded at the 2025 ILADS Conference in San Antonio, Texas, this conversation explores Dr. Shor's decades of experience studying chronic fatigue syndrome, Lyme disease, and associated tick-borne infections.
Dr. Shor discusses the evolution of his clinical approach, including the growing role of nutraceuticals, research into disulfiram for Borrelia persister cells, and the increasing recognition of patients with multiple tick-borne infections.
He also explains how clinicians can use symptom patterns to investigate the three Bs—Borrelia, Bartonella, and Babesia—and discusses emerging laboratory technologies such as PCR, FISH, and urine antigen testing.
The interview concludes with a celebration of Dr. Shor's contributions to Lyme disease research, medical education, and patient advocacy as he prepares to receive one of ILADS' most significant honors.
For patients who have spent years searching for answers, Dr. Shor's work represents decades of commitment to understanding persistent illness and advancing the conversation around Lyme disease.
Meet Dr. Samuel Shor, MD, FILADS
Dr. Samuel Shor is an internal medicine physician whose interest in chronic fatigue and complex illness began in the late 1980s.
His clinical experiences eventually led him to investigate possible relationships between chronic fatigue syndrome and Lyme disease.
Over the following decades, he became involved in Lyme disease research, medical education, and advocacy.
His professional contributions include:
Serving as president of ILADS
Contributing to peer-reviewed research on Lyme disease
Leading the development of an ILADS definition of chronic Lyme disease
Investigating the relationship between chronic fatigue syndrome and Lyme disease
Studying integrative treatment approaches involving nutraceuticals
Educating clinicians about Lyme disease and associated infections
Advocating for greater recognition of patients with persistent symptoms
Dr. Shor has also participated in public policy and educational initiatives, including presentations on Capitol Hill and service on the Virginia Governor's Task Force on Lyme Disease.
His contributions have helped shape discussions about the diagnosis, treatment, and research priorities surrounding persistent Lyme disease symptoms.
From Chronic Fatigue Syndrome to Lyme Disease Research
Dr. Shor explains that his interest in complex chronic illness began early in his medical career.
During the late 1980s, he encountered patients experiencing persistent fatigue and other symptoms that were difficult to explain.
He became particularly interested in chronic fatigue syndrome, now commonly referred to as myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
Over time, he began investigating whether Lyme disease might be contributing to symptoms in some of these patients.
During the interview, Dr. Shor references research involving more than 200 patients with chronic fatigue syndrome.
He explains that his findings suggested an association between Lyme disease and symptoms experienced by a substantial portion of this patient population.
His work contributed to his growing interest in chronic Lyme disease and the need for further research into persistent symptoms.
ME/CFS and Lyme disease are distinct diagnoses, and research has not established that most cases of ME/CFS are caused by Lyme disease.
However, overlapping symptoms such as fatigue, cognitive difficulties, pain, and reduced physical functioning can make differential diagnosis challenging.
Dr. Shor's experience illustrates how investigating unexplained symptoms can generate important clinical and research questions.
How Lyme Disease Treatment Has Evolved
Rich asks Dr. Shor how his treatment approach has changed over the past 15 years.
Dr. Shor explains that his understanding of Lyme disease and associated infections has evolved alongside new research.
He continues to recognize antimicrobial medications as an important component of treatment for appropriately diagnosed bacterial infections.
However, he also discusses the growing role of complementary approaches in his practice.
One area of particular interest is nutraceuticals, including herbal products and nutritional supplements.
Dr. Shor describes using these products as adjunctive therapies and, in some circumstances, as part of longer-term management strategies.
He emphasizes that he does not want to use antibiotics longer than necessary.
His goal is to consider different treatment options while balancing potential benefits and risks.
The effectiveness of individual nutraceuticals for persistent Lyme disease symptoms remains uncertain, and supplements should not be assumed to eliminate Borrelia or other infections.
What Are Nutraceuticals?
During the interview, Rich asks Dr. Shor to explain the term nutraceutical.
Dr. Shor describes nutraceuticals as products such as:
Herbal preparations
Nutritional supplements
Other nonprescription products used to support health
These products are sometimes incorporated into integrative treatment plans.
Dr. Shor explains that he has become increasingly interested in their potential role alongside or following conventional antimicrobial treatment.
However, over-the-counter availability does not establish that a product is safe or effective.
Herbal products and supplements can cause adverse effects, interact with medications, and vary in quality and composition.
Patients should discuss supplements with qualified healthcare professionals, particularly when managing multiple medications or medical conditions.
Disulfiram and Borrelia Persister Cells
One of the most scientifically interesting portions of the interview focuses on disulfiram, a medication traditionally used in the treatment of alcohol use disorder.
Dr. Shor explains that laboratory researchers have investigated disulfiram's activity against Borrelia burgdorferi.
He is particularly interested in research involving bacterial persister cells.
Persister cells are bacterial populations that can survive exposure to certain antimicrobial treatments under laboratory conditions.
Researchers have investigated whether these cells may contribute to difficulties eliminating Borrelia under some circumstances.
Dr. Shor describes laboratory findings suggesting that disulfiram may have activity against certain Borrelia forms.
These discoveries have encouraged further investigation into whether the medication might have clinical applications for patients experiencing persistent symptoms after Lyme disease treatment.
An important distinction: Activity against bacteria in a laboratory does not establish that a medication is effective or safe for treating patients.
Disulfiram is not FDA-approved for Lyme disease.
A small published pilot study involving patients with persistent symptoms after Lyme disease treatment identified possible improvements in some participants but also significant tolerability and safety concerns.
Disulfiram can cause serious adverse effects, including neurological complications, liver injury, and interactions with alcohol and other substances.
Its use for Lyme disease remains investigational and requires careful medical oversight.
Are Patients Being Diagnosed With More Tick-Borne Coinfections?
Rich raises a question based on Tick Boot Camp's extensive interview experience.
After speaking with hundreds of patients, he has observed that more recent guests frequently report diagnoses involving multiple infections rather than Borrelia alone.
He asks Dr. Shor whether the change reflects:
More pathogens circulating in ticks
Increased exposure to infected ticks
Improvements in diagnostic testing
Greater clinical awareness of coinfections
Dr. Shor believes several factors may be contributing.
He explains that researchers are identifying multiple organisms in ticks and that clinicians are increasingly evaluating patients for additional infections.
He also emphasizes the importance of recognizing clinical features that may suggest particular pathogens.
The frequency of multiple positive test results in a specialty practice or podcast population does not establish that most Lyme disease patients have several active infections.
Nevertheless, coinfections are an important consideration when a patient's symptoms, exposure history, and diagnostic findings support further evaluation.
The Three Bs: Borrelia, Bartonella, and Babesia
Dr. Shor discusses three organisms frequently considered during evaluations for Lyme disease and associated infections.
He explains that different infections may produce overlapping symptoms but can also have distinguishing clinical features.
Borrelia: Migrating Joint Pain
Borrelia burgdorferi is the primary cause of Lyme disease in the United States.
Dr. Shor highlights migratory polyarthralgia, meaning pain affecting multiple joints that changes location.
For example, a patient might experience pain in one knee on a particular day and pain in an elbow or another joint later.
Migrating joint pain can occur in Lyme disease, although it is not exclusive to Lyme and does not establish a diagnosis on its own.
Bartonella: Foot Pain and Urinary Symptoms
Dr. Shor describes observing certain symptoms among patients he evaluates for Bartonella, including:
Pain in the bottoms of the feet
Urinary urgency
Urinary frequency
Bladder irritation
He explains that these features may prompt him to investigate Bartonella.
However, these symptoms have many
What if some patients living with fibromyalgia, POTS, chronic pain, or Long COVID have an overlooked tick-borne infection? And what happens when a physician begins investigating infections that were never previously considered?
In this LIVE from ILADS episode of the Tick Boot Camp Podcast, co-host Rich Johannesen interviews Dr. Jade Stefano, ND, a Seattle-based naturopathic physician specializing in integrative medicine, complex chronic illness, Lyme disease, and associated infections.
Recorded at the 2025 International Lyme and Associated Diseases Society (ILADS) Conference in San Antonio, Texas, the conversation explores Dr. Stefano's growing interest in Borrelia, Bartonella, Babesia, and other vector-borne infections among patients experiencing persistent, often disabling symptoms.
Dr. Stefano shares how her mother's complicated medical history inspired her to investigate tick-borne illnesses more closely.
What began with one family member quickly expanded.
Over approximately one year, Dr. Stefano reports identifying evidence of tick-borne infections in 11 family members and more than 20 patients previously being treated for complex chronic illnesses.
Many of these patients had diagnoses or symptoms involving fibromyalgia, postural orthostatic tachycardia syndrome (POTS), Ehlers-Danlos syndrome (EDS), mast cell activation syndrome (MCAS), chronic pain, or Long COVID.
She also discusses specialized laboratory testing, potential relationships between viral illness and other infections, and her experiences treating patients with severe medical complications.
The conversation concludes with an intriguing discussion about neuroplasticity, ketamine-assisted psychotherapy, psychedelic integration, and the possibility of incorporating brain-focused therapies into complex chronic illness care.
Could a broader diagnostic approach help some patients discover previously overlooked medical conditions?
Dr. Stefano believes clinicians should remain curious, investigate plausible explanations, and avoid assuming that patients with complex symptoms have exhausted their options.
Meet Dr. Jade Stefano, ND
Dr. Jade Stefano is a licensed naturopathic physician practicing in Seattle, Washington, with additional licensure in Vermont.
She completed her naturopathic medical training at Bastyr University and holds a biology degree from Reed College.
Her clinical interests include:
Lyme disease and associated tick-borne infections
Complex chronic illness
Integrative cardiology
Chronic pain and inflammatory conditions
Environmental medicine
Integrative mental health
Botanical and pharmaceutical medicine
Ketamine-assisted psychotherapy
Psychedelic integration and harm reduction
Medical cannabis
During the interview, Dr. Stefano explains that she works with patients who have complicated medical histories, including individuals receiving palliative and supportive care.
Her approach combines conventional medical evaluation with selected naturopathic and integrative therapies.
Learn more about her practice at Dr. Jade Stefano's official website and read her professional biography.
How Her Mother's Illness Changed Her Medical Career
Dr. Stefano explains that her growing focus on tick-borne infections began with her mother.
Originally from the East Coast, her mother had been diagnosed with Lyme disease approximately 20 years earlier.
According to Dr. Stefano, she received an extended course of doxycycline under the care of Dr. Leo Galland.
Although her Lyme disease treatment eventually ended, she continued experiencing chronic health problems.
Over the years, she consulted multiple healthcare professionals without finding a satisfactory explanation for all her symptoms.
Dr. Stefano eventually decided to revisit the possibility of vector-borne infections.
She ordered additional testing, which she reports identified evidence of Babesia odocoilei.
The result prompted her to investigate other family members who had experienced unexplained symptoms.
She describes discovering additional positive laboratory findings and becoming increasingly interested in the possibility that tick-borne infections had been overlooked.
Her mother's experience became a turning point in her clinical career.
Eleven Family Members and More Than 20 Patients
One of the most striking moments in the interview occurs when Dr. Stefano describes the scale of her discoveries.
Over approximately 11 months, she reports identifying tick-borne infection markers in 11 family members and more than 20 patients from her existing practice.
These were not necessarily patients who initially came to her seeking Lyme disease treatment.
Many had longstanding diagnoses involving chronic pain, autonomic dysfunction, fibromyalgia, or other complex conditions.
She explains that some had spent years receiving treatments focused primarily on symptom management.
Her observations led her to question whether additional infectious disease evaluation might be appropriate for certain patients.
These findings reflect Dr. Stefano's experience in a highly selected group of family members and patients. They do not establish the prevalence of tick-borne infections among people with fibromyalgia, POTS, EDS, MCAS, or Long COVID.
Positive specialty laboratory findings also require careful interpretation and do not automatically establish active infection or causation.
Why Lyme Disease Can Be Overlooked in the Pacific Northwest
Rich and Dr. Stefano discuss the perception that Lyme disease is primarily an East Coast problem.
Dr. Stefano explains that tick-borne infections were not a major focus of her initial naturopathic education or early clinical work in Seattle.
She describes encountering patients whose symptoms had been evaluated extensively without much attention to possible vector-borne exposures.
Her personal experiences eventually prompted her to pursue additional training through ILADS.
She also recalls discovering a tick crawling on her leg while sitting on her front porch in Seattle.
The tick was submitted for testing and reportedly tested negative.
The experience reinforced her awareness that tick encounters are not limited to remote forests or hiking trails.
Tick species, infection prevalence, and disease risk vary considerably by region. Although locally acquired Lyme disease is much less common in Washington than in the Northeast, exposure is possible, and travel history remains important.
Patients and clinicians should consider geography, exposure history, symptoms, and validated testing when evaluating possible tick-borne infections.
For practical prevention information, explore the Tick Boot Camp Tick Bite Blueprint.
Lyme Disease, Bartonella, and Babesia: Understanding the Three Bs
Rich asks Dr. Stefano about the increasing number of Tick Boot Camp guests who report diagnoses involving multiple organisms.
The discussion centers on the three Bs:
Borrelia, Bartonella, and Babesia.
Borrelia
Borrelia burgdorferi is the primary bacterial cause of Lyme disease in the United States.
Lyme disease can affect multiple body systems and may cause fever, fatigue, joint symptoms, neurological complications, and other manifestations.
Bartonella
Bartonella is a group of bacteria associated with several human diseases, including cat-scratch disease.
Some Bartonella species are transmitted by fleas, lice, or other established routes.
The extent to which ticks transmit Bartonella to humans remains uncertain, and positive Bartonella tests do not automatically establish that a patient's chronic symptoms are caused by active infection.
Babesia
Babesia organisms are parasites that infect red blood cells.
Certain species cause babesiosis, a tick-borne illness that can range from asymptomatic infection to severe disease.
Dr. Stefano specifically discusses Babesia odocoilei, an organism historically associated with deer and other animals.
Its role in human disease remains an emerging and disputed area of investigation.
Other Possible Infections
Dr. Stefano also discusses tick-borne relapsing fever organisms and the possibility of multiple infections or exposures.
Her clinical observations emphasize the importance of considering more than one diagnosis when symptoms and exposure histories warrant investigation.
However, multiple infections should not be assumed without appropriate evidence.
Specialized Lyme and Coinfection Testing: What Is FISH?
Dr. Stefano expresses particular enthusiasm for fluorescence in situ hybridization, commonly called FISH testing.
FISH is a laboratory technique that uses fluorescent probes to identify specific genetic sequences within a specimen.
During the interview, she describes using specialty laboratory tests to investigate Babesia and Bartonella.
She reports that a substantial proportion of selected patients tested positive using certain FISH assays.
Dr. Stefano believes these findings have helped her identify infections that were previously overlooked.
However, diagnostic performance varies by organism, assay, laboratory, and clinical setting.
A positive FISH result should not automatically be considered definitive evidence of active infection, and sensitivity or specificity claims require validation for the specific test being used.
For Lyme disease, recommended two-tier antibody testing remains an important diagnostic method. Different tick-borne infections require different testing strategies.
Learn more through Tick Boot Camp's Lyme Disease Testing Resource.
Could Bartonella Be Connected to Long COVID?
One of the most provocative topics involves Dr. Stefano's patients with persistent symptoms following COVID-19.
She explains that some patients initially diagnosed with Long COVID had undergone evaluations for other possible contributors, including Epstein-Barr virus.
When symptoms persisted, she began investigating additional infectious possibilities.
Dr. Stefano reports finding positive Bartonella laboratory results in some of these patients.
She raises the possibility that SARS-C








